Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01155167 · ClinicalTrials.gov registry record · Phase 2
Topical Radial Artery Vasodilation
A Phase 2 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 2
- Development phase
- 86
- Enrollment target
NCT01155167 is a Phase 2 study that has completed, run by University of California, San Francisco. The registered enrollment target is 86 participants.
The verdict
NCT01155167, a Phase 2 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 86 participants
- Enrollment target
Study Summary
The aim of the study is to facilitate radial artery access for cardiac catheterization. The investigators hypothesize that topical nitroglycerin and lidocaine will reduce radial artery spasm. Patients undergoing cardiac catheterization via the radial artery will be randomized to topical nitroglycerin + lidocaine versus placebo.
Interventions
- OTHER Placebo
- DRUG Nitroglycerin and lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01155167
The ClinicalTrials.gov registry entry for NCT01155167 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01155167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01155167 about?
NCT01155167 is a clinical study titled "Topical Radial Artery Vasodilation". The aim of the study is to facilitate radial artery access for cardiac catheterization. The investigators hypothesize that topical nitroglycerin and lidocaine will reduce radial artery spasm. Patients undergoing cardiac catheterization via the radial artery will be randomized to topical nitroglyceri...
What is the current status of trial NCT01155167?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 86 participants. The study started on 2010-07. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01155167?
The interventions under investigation include: Placebo (OTHER), Nitroglycerin and lidocaine (DRUG).
Who is sponsoring clinical trial NCT01155167?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.